ADHD and University: Why the Transition Is So Hard, and What Actually Helps
For a lot of young people, university is sold as…
Attention-Deficit/Hyperactivity Disorder (ADHD) medications – particularly stimulants such as methylphenidate (e.g. Concerta, Medikinet) and lisdexamfetamine (Elvanse) – are widely prescribed across the UK under NICE guideline NG87. While these treatments are highly effective for many people, it is not uncommon for individuals to report that their medication “stops working” over time.
This blog explores the evidence-based reasons why ADHD medication may appear to lose efficacy, with a UK clinical context, and outlines what might actually be happening.
1. True Pharmacological Tolerance (Less Common Than You Think)
One of the most widely cited explanations is drug tolerance, where the body adapts to a medication and requires higher doses to achieve the same effect.
However, research increasingly shows that:
Key takeaway: While tolerance is possible, it is often overestimated as the primary cause of reduced effectiveness.
2. The “Honeymoon Effect” Wearing Off
Many patients experience an initial surge of clarity, motivation, and focus when starting ADHD medication.
This can lead to the perception that the medication has stopped working when, in reality, only the initial intensity has reduced. [scienceinsights.org]
Key takeaway: Early changes in how medication “feels” are normal and not necessarily a sign of reduced efficacy.
3. Incorrect or Suboptimal Dosing
In the UK, NICE guidelines emphasise careful titration and ongoing review of ADHD medication. [medxdrg.com]
NICE recommends:
Key takeaway: What feels like “medication failure” is often a dosing issue.
4. Lifestyle Factors: Sleep, Stress, and Diet
Medication effectiveness is heavily influenced by day-to-day lifestyle factors.
Common issues include:
These factors are frequently cited as more common explanations than pharmacological tolerance. [ryansultan.com]
Key takeaway: ADHD medication does not work in isolation – lifestyle stability is crucial.
5. Inconsistent Adherence
In real-world settings, adherence to ADHD medication is often inconsistent:
NICE highlights adherence monitoring as a core part of ADHD management. [nice.org.uk]
Key takeaway: Irregular use can mimic reduced efficacy.
6. Switching Needs: Not All Stimulants Work the Same
There are two main stimulant classes:
Patients often respond differently:
NICE recommends switching to an alternative stimulant if the first is ineffective. [iatrox.com]
Key takeaway: Lack of effect may reflect the wrong medication, not treatment failure.
7. Comorbid Conditions and Changing Clinical Picture
ADHD rarely exists in isolation. Common co-occurring conditions include:
If these emerge or worsen:
Additionally, ADHD symptoms themselves can fluctuate over time, especially with life transitions or increasing responsibilities. [adhdevidence.org]
Key takeaway: Changes in mental health or life context can reduce perceived effectiveness.
8. Acute Tolerance (Tachyphylaxis)
Some individuals experience within-day decline in effect, known as tachyphylaxis.
👉 Key takeaway: Not all “loss of effect” happens over months – some happens within a single day.
9. Lack of Holistic Treatment Approach
NICE guidance emphasises that medication should be part of a broader treatment plan, including:
Medication alone may not be sufficient, especially in adulthood.
Key takeaway: Over-reliance on medication can limit overall effectiveness.
Final Thoughts
The idea that ADHD medication “stops working” is common – but often misunderstood. In most cases, the cause is multifactorial, not simply tolerance.
The main drivers include:
Under UK NICE guidance, regular review and collaborative management with a specialist are essential to maintain treatment effectiveness.
References
© 2026 Makewell Health and Wellness Clinic